Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.770
+0.090 (2.45%)
Nov 13, 2026, 4:00 PM EST - Market closed
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $287.96 million as of November 13, 2026. It is the 18,227th most valuable company in the world and the 3,209th biggest in the United States. Its market cap has decreased by 36.35% in one year.
Market Cap
287.96M
Enterprise Value
-11.76M
1-Year Change
-36.35%
Global Rank
Country Rank
#3,209 United States
Category
ChartMarket Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has decreased from $301.64M to $287.96M, a decrease of -4.54%. That is a compound annual growth rate of -0.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 287.96M | -61.41% |
| Dec 31, 2025 | 746.12M | 194.32% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inhibikase Therapeutics | 305.27M |
| Agenus | 304.51M |
| PepGen | 301.97M |
| Century Therapeutics | 299.64M |
| Nautilus Biotechnology | 295.50M |
| Allogene Therapeutics | 290.58M |
| Precision BioSciences | 288.76M |
| Vicore Pharma Holding AB | 282.67M |